We are live on ! Find out more
RG

Renaissance Group Portfolio holdings

AUM $2.39B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+27.81%
3 Year Est. Return
+92.11%
5 Year Est. Return
+135.4%
10 Year Est. Return
+451.85%
AUM
$2.31B
AUM Growth
+$133M
Cap. Flow
-$2.47M
Cap. Flow %
-0.11%
Top 10 Hldgs %
16.06%
Holding
283
New
13
Increased
140
Reduced
117
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 34.54%
2 Healthcare 17.17%
3 Industrials 9.85%
4 Consumer Discretionary 8%
5 Financials 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
26
Roper Technologies
ROP
$38.8B
$32.1M 1.39%
66,704
-171
-0.3% -$77.4K
ITW icon
27
Illinois Tool Works
ITW
$82.6B
$32M 1.38%
128,067
-1,187
-0.9% -$278K
CI icon
28
Cigna
CI
$73.7B
$32M 1.38%
114,036
+110,704
+3,322% +$28.8M
AVGO icon
29
Broadcom
AVGO
$1.85T
$31.8M 1.37%
366,230
-137,180
-27% -$9.78M
CRM icon
30
Salesforce
CRM
$151B
$31.6M 1.36%
149,494
-1,110
-0.7% -$227K
MAR icon
31
Marriott International
MAR
$98.3B
$31.3M 1.35%
+170,582
New +$29.6M
KEYS icon
32
Keysight
KEYS
$54.5B
$31.3M 1.35%
+186,674
New +$29M
LOW icon
33
Lowe's Companies
LOW
$117B
$31.3M 1.35%
138,466
-498
-0.4% -$104K
MA icon
34
Mastercard
MA
$502B
$31.2M 1.35%
79,444
-177
-0.2% -$66.4K
V icon
35
Visa
V
$684B
$30.6M 1.32%
128,708
-172
-0.1% -$39.4K
PG icon
36
Procter & Gamble
PG
$336B
$30.5M 1.32%
201,084
-316
-0.2% -$47.6K
CDW icon
37
CDW
CDW
$18.9B
$30.2M 1.31%
164,772
+693
+0.4% +$121K
ANSS
38
DELISTED
Ansys
ANSS
$30M 1.3%
90,980
+359
+0.4% +$114K
LMT icon
39
Lockheed Martin
LMT
$134B
$29.3M 1.26%
63,583
-196
-0.3% -$91K
CHE icon
40
Chemed
CHE
$7.07B
$28.8M 1.24%
53,167
+39
+0.1% +$21.3K
UNH icon
41
UnitedHealth
UNH
$376B
$28.7M 1.24%
59,656
+5,192
+10% +$2.54M
CBRE icon
42
CBRE Group
CBRE
$42.5B
$28.4M 1.23%
352,294
+12,348
+4% +$925K
WEX icon
43
WEX
WEX
$6.37B
$28.4M 1.23%
155,844
+28,833
+23% +$5.11M
UNP icon
44
Union Pacific
UNP
$174B
$28.2M 1.22%
137,963
+2,998
+2% +$596K
EOG icon
45
EOG Resources
EOG
$79.2B
$28.1M 1.21%
245,745
+5,628
+2% +$643K
JNJ icon
46
Johnson & Johnson
JNJ
$618B
$27.6M 1.19%
166,927
+5,032
+3% +$812K
ABT icon
47
Abbott
ABT
$183B
$26.9M 1.16%
247,111
+33,736
+16% +$3.6M
TMO icon
48
Thermo Fisher Scientific
TMO
$213B
$26.9M 1.16%
51,591
+576
+1% +$311K
MO icon
49
Altria Group
MO
$114B
$26.4M 1.14%
582,485
+3,179
+0.5% +$144K
DHR icon
50
Danaher
DHR
$137B
$26M 1.12%
122,065
+21,037
+21% +$4.45M

Similar funds

Renaissance Group's Q2 2023 Portfolio in Review

As of Q2 2023, Renaissance Group held 283 positions worth $2.31B, up 6.1% from $2.18B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Renaissance Group's Q2 2023 filing shows 13 new, 140 increased, 117 reduced and 12 closed positions. Its largest new stake was Lam Research: 525,840 shares worth $33.8M. The largest sale was Texas Instruments, an estimated $28.7M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • Renaissance Group's largest Q2 2023 buy was Lam Research: 525,840 shares worth $33.8M.
  • Renaissance Group added most to Cigna in Q2 2023, an estimated $28.8M increase.
  • Renaissance Group's biggest Q2 2023 reduction was Texas Instruments, cutting an estimated $28.7M.
  • Renaissance Group fully exited Raymond James Financial in Q2 2023, selling an estimated $21.9M.
  • Renaissance Group's ten largest holdings make up 16% of its $2.31B portfolio in Q2 2023.
  • Renaissance Group opened 13 new positions and closed 12 in Q2 2023.
  • Renaissance Group's portfolio value rose 6.1% quarter-over-quarter to $2.31B.

Based on Renaissance Group's 13F filing for Q2 2023, filed 10 Aug 2023.